Chiome Bioscience Inc. (4583.T)
JPY 132.0
(3.13%)
JPY 132.0
(3.13%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 64.1 Million JPY | -10.31% |
| 2022 | 71.47 Million JPY | 21.05% |
| 2021 | 59.04 Million JPY | -33.85% |
| 2020 | 89.26 Million JPY | 33.97% |
| 2019 | 66.62 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 52.44 Million JPY | -11.12% |
| 2024 Q1 | 59 Million JPY | -7.96% |
| 2023 FY | 64.1 Million JPY | -10.31% |
| 2023 Q2 | 59.73 Million JPY | -18.86% |
| 2023 Q1 | 73.62 Million JPY | 3.0% |
| 2023 Q3 | 58.08 Million JPY | -2.76% |
| 2023 Q4 | 64.1 Million JPY | 10.36% |
| 2022 Q3 | 78.17 Million JPY | 0.0% |
| 2022 Q4 | 71.47 Million JPY | -8.57% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 683.01 Million JPY | 90.614% |
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -257.56% |
| GNI Group Ltd. | 2.33 Billion JPY | 97.249% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 97.122% |
| MEDINET Co., Ltd. | 67.48 Million JPY | 5.0% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 94.281% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | 38.081% |
| AnGes, Inc. | 1.61 Billion JPY | 96.033% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | 13.368% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 97.792% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | 80.086% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -34740.761% |
| Carna Biosciences, Inc. | 140.14 Million JPY | 54.255% |
| CanBas Co., Ltd. | 728 Thousand JPY | -8705.907% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | 27.038% |
| RaQualia Pharma Inc. | 147.93 Million JPY | 56.667% |
| Kidswell Bio Corporation | 875.65 Million JPY | 92.679% |
| PeptiDream Inc. | 2.4 Billion JPY | 97.333% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -1100.056% |
| Ribomic Inc. | 2.27 Million JPY | -2719.129% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -6410699900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -78.075% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -121.059% |
| CellSource Co., Ltd. | 305.92 Million JPY | 79.045% |
| FunPep Company Limited | 25.54 Million JPY | -150.996% |
| Kringle Pharma, Inc. | 364.05 Million JPY | 82.391% |
| Stella Pharma Corporation | 1.11 Billion JPY | 94.257% |
| TMS Co., Ltd. | 50.02 Million JPY | -28.15% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -206.717% |
| Cuorips Inc. | 1.04 Million JPY | -6046.405% |
| K Pharma,Inc. | 10.79 Million JPY | -493.913% |
| Takara Bio Inc. | 11.85 Billion JPY | 99.459% |
| ReproCELL Incorporated | 248.14 Million JPY | 74.165% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | 85.773% |
| StemCell Institute Inc. | 42.26 Million JPY | -51.689% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | 71.952% |
| CellSeed Inc. | 46.19 Million JPY | -38.787% |